Leah Croll, MD, Assistant Professor of Clinical Neurology at the Lewis Katz School of Medicine at Temple University, wrote a commentary for Medscape on Alzheimer’s disease medications Leqembi (approved by the U.S. Food and Drug Administration) and donanemab (awaiting FDA approval).
800-TEMPLE-MED
Schedule Appointment
SEARCH TEMPLE HEALTH